Acromegaly was defined as a syndrome by Pierre Marie in 1885, but in the form of either
acromegaly or acrogigantism has probably been a disorder of antiquity [1, 2]. It is one of the …

Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma.
Incidence is higher than previously thought. Due to increased morbidity and mortality, if not …

Acromegaly is a rare disease most often caused by the prolonged secretion of excess
growth hormone from a pituitary adenoma. The disease is associated with multiple …

The CLINICAL consequences of advanced acromegaly are disfigurement, disability, and
shortened life expectancy due to respiratory, metabolic, cardiovascular, and malignant …

Acromegaly is characterized by increased release of growth hormone and, consequently,
insulin-like growth factor I (IGF1), most often by a pituitary adenoma. Prolonged exposure to …

Dysregulated growth hormone (GH) hypersecretion is usually caused by a GH-secreting
pituitary adenoma and leads to acromegaly—a disorder of disproportionate skeletal, tissue …

Acromegaly is a rare disease caused by growth hormone hypersecretion, mostly from a
pituitary adenoma, driving insulin-like growth factor 1 overproduction. Manifestations include …

Acromegaly is an acquired disorder related to excessive production of growth hormone (GH)
and characterized by progressive somatic disfigurement (mainly involving the face and …

Acromegaly is a rare pituitary disorder with an estimated incidence of three to four cases per
million population per year (1). Because it is a chronic and slowly developing disease …

Introduction A CROMEGALY, a spectacular disorder of somatic growth and proportion, has
fascinated endocrinologists for the past century and was the first pituitary disorder to be …